BioSpace News Archive

Policy

Inotrem Announces an Extension of Its License Agreement for the Biomarker Soluble TREM-1 to Cardiovascular Diseases

Inotrem S.A. announced the signature of an exclusive license agreement with four major research organizations, under which it receives the exclusive worldwide rights for the biomarker soluble TREM-1 in cardiovascular diseases, and in particular acute myocardial infarction.

January 31, 2019
·
2 min read
Business

Elements from Neopharm Coming to Vitabeauti.com

Neopharm brings new product line to popular health and beauty products site

January 31, 2019
·
1 min read
Business

Gradiant Secures Four Water Recycling Projects in India, Highlights Importance of Superior and Affordable Wastewater Treatment

Expands operations in India with four Zero Liquid Discharge (ZLD) projects in the textile processing, dyestuff and alkali-chemical manufacturing, and pharmaceutical industries

January 31, 2019
·
4 min read
BioCapital

USP Announces Generics Access Plan

Quality standards can help increase the number of generic medicines available to patients

January 31, 2019
·
3 min read
Policy

Innovus Pharma Announces the Approval and Launch of its OTC Hemorrhoid Xyralid® Suppositories in Canada

Xyralid®, Suppositories for the Reduction of Swelling and Inflammation of Hemorrhoidal Tissues, is the Ninth Innovus Pharma Product launched in Canada to Date

January 31, 2019
·
4 min read
Business

Janssen Enters Worldwide Collaboration and License Agreement with MeiraGTx to Develop Gene Therapy Programs for Inherited Retinal Diseases

The Janssen Pharmaceutical Companies of Johnson & Johnson announced a worldwide collaboration and license agreement with MeiraGTx Holdings plc.

January 31, 2019
·
5 min read
Business

Alexion and Caelum Biosciences Announce Collaboration to Develop Targeted Therapy for Light Chain (AL) Amyloidosis

Collaboration provides opportunity to diversify Alexion’s clinical-stage rare hematology portfolio

January 31, 2019
·
7 min read
FDA

FDA Expands Lilly’s ALIMTA® (pemetrexed) Label with Combination of KEYTRUDA® (pembrolizumab) and Platinum Chemotherapy for the First-Line Treatment of Metastatic Nonsquamous Non-Small Cell Lung Cancer

New approval based on Phase 3 KEYNOTE-189 results

January 31, 2019
·
16 min read
Business

AmerisourceBergen Reports Fiscal 2019 First Quarter Results

Revenues of $45.4 Billion for the First Quarter, a 12.2 Percent Increase Year-Over-Year

January 31, 2019
·
36 min read
Business

Dadi Announces Launch With At-Home Fertility Test and Sperm Storage Kit Making Male Reproductive Health More Accessible

The company announces just under $2 million in funding to help men start healthy families in the future from the comfort of their own home

January 31, 2019
·
3 min read